The main goal of the Medical-Surgical Dermatology Department is to offer high-quality, effective specialist care in all medical and surgical areas relating to the prevention, diagnosis and treatment of skin disorders in adult patients at the University Hospital of Bellvitge and its areas of influence.
The Dermatology Department serves as a level-3 reference centre and its organisation is based on specialised units, offices and specialist consultations. The HUB Dermatology Department also covers level-1 dermatological care at CAP Just Oliveres and CAP Ramona, with a population of reference of almost 200,000 people.
Our mission includes the promoting of graduate and post-graduate education, clinical and translational research and innovation in the main areas of dermatology today, especially in our consolidated lines, such as malignant melanoma, cutaneous lymphoma and psoriasis.
Head of Service
Head of Nursing Area
- Malignant melanoma
Early diagnosis of premelanotic lesions Fotofinder and digital epiluminescence Integrated medical-surgical treatment Multidisciplinary treatment of advanced disease Clinical trials
- Cutaneous lymphomas
Unit of reference in cutaneous lymphoma Extensive experience in multidisciplinary clinical management (ICO/Bellvitge Functional Lymphoma Unit) Clinical and translational research Clinical trials
- Nonmelanoma skin cancer
Medical-surgical treatment of basal and squamous cell carcinoma Multidisciplinary skin cancer committee
Lines of research
- Prognostic factors and new therapeutic targeting in malignant melanoma
- Prognostic factors in cutaneous lymphoma
- Epigenetics and genetics in cutaneous T-cell lymphoma
- Pathogenesis and therapeutics in autoinflammatory diseases
- Biological therapy in psoriasis and autoimmune diseases
Cancer and human molecular genetics (IDIBELL)
Lymphoid and haematopoietic tumours (IDIBELL)
- Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene. JAMA Dermatology 2018
- The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2018
- AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. J Invest Dermatol 2017
- Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome. J Invest Dermatol 2016
- Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol 201
Adjunct Professor: Octavi Servitje Bedate. University of Barcelona. Dermatology Coordinator, Medicine Degree-Bellvitge Campus. Master’s Thesis Coordinator- Medicine Degree- Bellvitge Campus
Associate Professor: Joaquin Marcoval Caus. Medicine Degree-Bellvitge Campus
Associate Professor: Jucglà Serra. Medicine and Podiatry Degree-Bellvitge Campus
Associate Professor: Jaime Notario Rosa. Medicine Degree-Bellvitge Campus
Associate Professor: Cristina Muniesa Montserrat. Medicine and Podiatry Degree-Bellvitge Campus
Master's degrees and accredited courses
Residency programme training in Medical-Surgical
Residency programme training in Family and Community Medicine
Rotational training (internship programme) for Internal Medicine and Rheumatology Residents.
External rotation for Residents from other University Hospitals (Catalonia and Spain) for specific training (cutaneous lymphoma, Skin allergies, Laser therapy)
Consultes Externes de l'Hospital Universitari de Bellvitge
c/ Feixa Llarga, sn.
08907 L'Hospitalet de Llobregat. Barcelona
Telèfon 93 335 70 11